Previous investigators have demonstrated that prorenin and PRR are involved in the pathogenesis of renal and cardiac hypertrophy, accompanied by local oxidative stress, inflammation, and NLRP3-IL-1β-related signals [48, 49]. The gene discussed is NLRP3; the disease is cardiac hypertrophy.